medigraphic.com
ISSN 1561-302X (Print)

2022, Number 4

<< Back Next >>

Rev cubana med 2022; 61 (4)

Antisynthetase syndrome and its overlap with rheumatoid arthritis

Chico CA, Estévez TM, Hernández GR

Language: Spanish
References: 9
Page: 1-4
PDF size: 413.14 Kb.


ABSTRACT

Rheumatoid Arthritis and antisynthetase syndrome are two distinctive entities, the coexistence of which is rare. The case of a 48-year-old female patient with a 3-year history of RA who developed SAS is reported. The diagnosis was made by the positivity of the Anti-Jo 1 antibody, interstitial lung disease, polyarthritis, muscle weakness, mechanic's hands and other skin lesions.


REFERENCES

  1. Kyu Park Ch, Jong Kim T, Nan Cho Y, Soo Kim I, Jun Lee H, Eun Lee K et al. Development of antisynthetase syndrome in a patient with rheumatoid artritis. Reumatol Int. 2011;31:529-32.

  2. Baccaro ACCD, Behrens Pinto GL, Carboni RCS, Shinjo SK. The clinical manifestations at the onset of antisynthetase syndrome: A chameleon with multiple faces. Reumatismo. 2020 [acceso: 23/10/2021];72(2):86-92. Disponible en: https://reumatismo.org

  3. Emad Y, Ragab Y, Magdy Abd-Elsalam M, Johannes J, Rasker. Antisynthetase syndrome complicating VVN the course of established case with rheumatoid arthritis: a rare and under-recognized overlapping disease. Reumatol Clin. 2020 [acceso: 23/10/2021];16(5):419-22. Disponible en: https://www.reumatologiaclinica.org

  4. Daniel Aletaha D, Smolen J. Diagnosis and Management of Rheumatoid Arthritis. A Review. JAMA. 2018 [acceso: 23/10/2021];320(13):1360-72. Disponible en: https://pubmed.nsbi.nlm.nih.gov

  5. Omar A, Abo-Elyoun I, Hussein H, Nabih M, Atwa H, Gad S, et al. Anti-cyclic citrullinated peptide (anti-CCP) Antibody in juvenile idiopathic arthritis (JIA): correlations with disease activity and severity of joint damage (a Multicenter trial). Joint Bone Spine.2013;80:38-43.

  6. Meyer A, Lefevre G, Bierry G, Duval A, Messer L, Buchdahl AL et al. In AntisynthetaseSyndrome, ACPA Are Associated With Severe and Erosive Arthritis. Medicine.2015;94(20):523.

  7. Masiak A, Marzec M, Kulczycka J, Zdrojewski Z. The clinical phenotype associated withantisynthetase autoantibodies. Reumatol. 2020 [acceso: 23/10/2021];58(1):4-8.https://pubmed.nsbi.nlm.nih.gov

  8. Marin FL, Pereira Sampaio H. Antisynthetase Syndrome and Autoantibodies: ALiterature Review and Report of 4 Cases. Am J Case Rep. 2019;20:1094-103. Disponibleen: https://www. pubmed.nsbi.nlm.nih.gov

  9. Júdez Navarro E, Martínez Carreterob M Martínez Jiménez b GF. Síndrome antisintetasasin afectación muscular. Reumatol Clin. 2007;3(6):276-7.




2020     |     www.medigraphic.com